Related Experiment Videos
Acute tryptophan depletion in schizophrenia
K L Golightly1, J A Lloyd, J E Hobson
1School of Neurosciences, Division of Psychiatry, University of Newcastle-upon-Tyne.
Psychological Medicine
|February 24, 2001
Summary
Acute tryptophan depletion selectively impairs executive function in schizophrenia patients. This method did not affect mood, movement disorders, or overall symptom scores in the study.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Brain 5-hydroxytryptamine (5-HT) pathways are crucial in schizophrenia pathophysiology and antipsychotic drug action.
- Acute tryptophan depletion (ATD) is a method to selectively manipulate 5-HT levels.
- Understanding 5-HT's role is key for developing targeted schizophrenia treatments.
Purpose of the Study:
- To investigate the effects of ATD on schizophrenia symptoms, mood, and cognitive functions.
- To determine if selective 5-HT modulation impacts clinical presentation in schizophrenia.
Main Methods:
- A within-subject, double-blind, placebo-controlled, counterbalanced cross-over study.
- Twenty-eight schizophrenia patients underwent ATD or placebo drink.
- Evaluated symptoms, mood, and cognitive performance post-intervention.
Main Results:
- ATD significantly reduced plasma total and free tryptophan, confirming selective 5-HT depletion.
- Impairment in executive function was observed following ATD, order-dependent.
- No significant effects on sustained attention, processing speed, memory, mood, or movement disorders.
Conclusions:
- Acute tryptophan depletion selectively impacts cognitive function in schizophrenia.
- ATD does not appear to influence subjective mood ratings or motor symptoms in this patient group.
- Findings suggest a specific role for 5-HT in schizophrenia-related executive dysfunction.